Insiders · TXMD

Jules A. Musing

Director at TherapeuticsMD, Inc. (TXMD)

Jules A. Musing has filed 4 insider reports with the SEC since July 2021, as director at TherapeuticsMD, Inc. (TXMD). The latest filing, on October 3, 2022, reports grant or award at TherapeuticsMD, Inc. (TXMD).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Jules A. Musing is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
TherapeuticsMD, Inc. logo
TXMD
TherapeuticsMD, Inc.
Director4,022$1.81Oct 3, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jules A. Musing with

Other insiders at the same companies

Questions about Jules A. Musing

What is Jules A. Musing's role at TherapeuticsMD, Inc.?
Jules A. Musing reports to the SEC as director at TherapeuticsMD, Inc. (TXMD), according to the latest filing on October 3, 2022.
How many shares does Jules A. Musing own?
After the latest filing that states it, Jules A. Musing directly owned 4,022 shares of TherapeuticsMD, Inc. (TXMD). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jules A. Musing bought or sold stock recently?
No open-market purchases or sales by Jules A. Musing are on file. The filings report grant or award and exercise or conversion of a derivative.
How do I get alerts when Jules A. Musing files?
Follow Jules A. Musing on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jules A. Musing (SEC CIK 0001524216). Totals count each trade once, skipping amendments whose original is on file, from Jul 2, 2021 on. View on SEC EDGAR